Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01155882 · ClinicalTrials.gov registry record
Registry Study - Whipple at the Splenic Artery
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 13
- Enrollment target
NCT01155882: Completed study, sponsored by Washington University School of Medicine.
NCT01155882 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01155882 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how effective Whipple at the Splenic Artery (WATSA).
Primary Outcome
To determine how effective Whipple at the Splenic Artery (WATSA) is at resecting tumors with negative microscopic margins (R0) at the resection line on the pancreas and at the tangential posterior, uncinate, and venous margins.
Interventions
- PROCEDURE Whipple at the Splenic Artery (WATSA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-09-20 |
| Est. Completion | 2019-01-16 |
What the finished NCT01155882 record still lists
NCT01155882 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Whipple at the Splenic Artery (WATSA) is the first listed.
NCT01155882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01155882 about?
NCT01155882 is a clinical study titled "Registry Study - Whipple at the Splenic Artery". The purpose of this study is to determine how effective Whipple at the Splenic Artery (WATSA).
What is the current status of trial NCT01155882?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2010-09-20. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT01155882?
The interventions under investigation include: Whipple at the Splenic Artery (WATSA) (PROCEDURE).
Who is sponsoring clinical trial NCT01155882?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI